189 related articles for article (PubMed ID: 18006380)
1. Thrombin generation capacity is impaired in methylene-blue treated plasma compared to normal levels in single-donor fresh-frozen plasma, a licensed solvent/detergent-treated plasma (Octaplas) and a development product (Uniplas).
Pock K; Heger A; Janisch S; Svae TE; Römisch J
Transfus Apher Sci; 2007 Dec; 37(3):223-31. PubMed ID: 18006380
[TBL] [Abstract][Full Text] [Related]
2. A biochemical comparison of a pharmaceutically licensed coagulation active plasma (Octaplas) with a universally applicable development product (Uniplas) and single-donor FFPs subjected to methylene-blue dye and white-light treatment.
Heger A; Römisch J; Svae TE
Transfus Apher Sci; 2006 Dec; 35(3):223-33. PubMed ID: 17118709
[TBL] [Abstract][Full Text] [Related]
3. Coagulation function in fresh-frozen plasma prepared with two photochemical treatment methods: methylene blue and amotosalen.
Osselaer JC; Debry C; Goffaux M; Pineau J; Calomme G; Dubuc E; Chatelain B; Vandendaele MC; Hsu J; Rheinschmidt M; Lin L
Transfusion; 2008 Jan; 48(1):108-17. PubMed ID: 17900283
[TBL] [Abstract][Full Text] [Related]
4. [Initial experiences with methylene blue virus inactivated fresh frozen plasma: results of a clinical and in vitro study].
Wieding JU; Neumeyer H
Infusionsther Transfusionsmed; 1992 Apr; 19(2):84-90. PubMed ID: 1623325
[TBL] [Abstract][Full Text] [Related]
5. Stability of solvent/detergent-treated plasma and single-donor fresh-frozen plasma during 48 h after thawing.
Heger A; Römisch J; Svae TE
Transfus Apher Sci; 2005 Nov; 33(3):257-67. PubMed ID: 16203177
[TBL] [Abstract][Full Text] [Related]
6. The influence of methylene blue light treatment and methylene blue removal filter on fibrinogen activity states and fibrin polymerisation indices.
Depasse F; Sensebé L; Seghatchian J; Andreu G; Samama MM
Transfus Apher Sci; 2005 Aug; 33(1):63-9. PubMed ID: 16029868
[TBL] [Abstract][Full Text] [Related]
7. Quantitative and qualitative analysis of proteins in fresh frozen plasma obtained from whole blood donations and prepared with two photochemical treatments.
Cid J; Ramiro L; Martínez N; Palomo M; Magallon O; Claparols M; Ortiz P; Puig L; Pla RP
Transfus Apher Sci; 2008 Oct; 39(2):115-21. PubMed ID: 18710822
[TBL] [Abstract][Full Text] [Related]
8. West Nile virus in plasma is highly sensitive to methylene blue-light treatment.
Mohr H; Knüver-Hopf J; Gravemann U; Redecker-Klein A; Müller TH
Transfusion; 2004 Jun; 44(6):886-90. PubMed ID: 15157256
[TBL] [Abstract][Full Text] [Related]
9. [Activity and concentration determinations of coagulation factors in conventional and virus-inactivated coagulation-active plasma].
Lutze G; Hartung KJ
Beitr Infusionsther Transfusionsmed; 1994; 32():415-8. PubMed ID: 9480135
[TBL] [Abstract][Full Text] [Related]
10. Thrombin generation and clot formation in methylene blue-treated plasma and cryoprecipitate.
Cardigan R; Philpot K; Cookson P; Luddington R
Transfusion; 2009 Apr; 49(4):696-703. PubMed ID: 19170989
[TBL] [Abstract][Full Text] [Related]
11. Fresh-frozen plasma, pathogen-reduced single-donor plasma or bio-pharmaceutical plasma?
Hellstern P
Transfus Apher Sci; 2008 Aug; 39(1):69-74. PubMed ID: 18583192
[TBL] [Abstract][Full Text] [Related]
12. [Methylene blue/light treatment of virus inactivated human plasma: production and clinical experience].
Mohr H; Pohl U; Lambrecht B; Wieding JU; Schmitt H
Infusionsther Transfusionsmed; 1993 Jun; 20 Suppl 2():19-24. PubMed ID: 8374283
[TBL] [Abstract][Full Text] [Related]
13. Storage of thawed plasma for a liquid plasma bank: impact of temperature and methylene blue pathogen inactivation.
Thiele T; Kellner S; Hron G; Wasner C; Nauck M; Zimmermann K; Wessel A; Warkentin TE; Greinacher A; Selleng K
Transfusion; 2012 Mar; 52(3):529-36. PubMed ID: 21880044
[TBL] [Abstract][Full Text] [Related]
14. Update on pathogen reduction technology for therapeutic plasma: an overview.
Solheim BG; Seghatchian J
Transfus Apher Sci; 2006 Aug; 35(1):83-90. PubMed ID: 16934528
[TBL] [Abstract][Full Text] [Related]
15. Rapid inactivation of HIV-1 in single donor preparations of human fresh frozen plasma by methylene blue/light treatment.
Lambrecht B; Norley SG; Kurth R; Mohr H
Biologicals; 1994 Sep; 22(3):227-31. PubMed ID: 7811456
[TBL] [Abstract][Full Text] [Related]
16. Coagulation factor content of solvent/detergent plasma compared with fresh frozen plasma.
Doyle S; O'Brien P; Murphy K; Fleming C; O'Donnell J
Blood Coagul Fibrinolysis; 2003 Apr; 14(3):283-7. PubMed ID: 12695752
[TBL] [Abstract][Full Text] [Related]
17. Photodynamic inactivation of model virus in human plasma by methylene blue and its influence on plasma proteins.
Wang D; Bu F; Xu J
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2000 Mar; 14(1):52-5. PubMed ID: 11503026
[TBL] [Abstract][Full Text] [Related]
18. Cryoprecipitate prepared from plasma treated with methylene blue plus light: increasing the fibrinogen concentration.
Hornsey VS; Young DA; Docherty A; Hughes W; Prowse CV
Transfus Med; 2004 Oct; 14(5):369-74. PubMed ID: 15500456
[TBL] [Abstract][Full Text] [Related]
19. Quantitative evaluation of plasma after methylene blue and white light treatment in four Chinese blood centers.
Chunhui Y; Guohui B; Hong Y; Xiaopu X; Zherong B; Mingyuan W; Xinsheng Z; Juanjuan W; Changqing L; Wuping L
Transfus Apher Sci; 2013 Dec; 49(3):631-9. PubMed ID: 23928128
[TBL] [Abstract][Full Text] [Related]
20. Paired comparison of methylene blue- and amotosalen-treated plasma and cryoprecipitate.
Backholer L; Wiltshire M; Proffitt S; Cookson P; Cardigan R
Vox Sang; 2016 May; 110(4):352-61. PubMed ID: 26757252
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
